Subsequently, we assessed whether miR-708 inhibited SPHK2 expression using RT-PCR and western blotting and revealed that miR-708 decreased both mRNA and protein SPHK2 levels in LN382 and GBM-GY cells (Fig. 4c, d). This evidence concerns the gene SPHK2 and glioblastoma.